12 results
2021 ACR/VF Guidelines for Management of Eosinophilic Granulomatosis with Polyangiitis (EGPA)

#EGPA #Eosinophilic #Granulomatosis #Polyangiitis #ACR2021 #Management
2021 ACR/VF Guidelines ... for Management ... of Eosinophilic Granulomatosis ... #Polyangiitis #ACR2021 ... #Management #rheumatology
2021 ACR/VF Guidelines for Management of Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)

#Granulomatosis #Polyangiitis #GPA
2021 ACR/VF Guidelines ... for Management ... of Granulomatosis ... Polyangiitis #MPA #ACR2021 ... #Management #rheumatology
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
- ACR/VF 2021 Guidelines ... Nodosa (PAN) • Granulomatosis ... • Eosinophilic Granulomatosis ... #Treatment #ACR2021 ... #Guidelines #algorithm
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021
Granulomatosis with ... ANCA Vasculitis Management ... Algorithm - ACR ... /VF 2021 Guidelines ... #Treatment #ACR2021
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active
Eosinophilic Granulomatosis ... ANCA Vasculitis Management ... Algorithm - ACR ... /VF 2021 Guidelines ... #Treatment #ACR2021
Cardiac Valve Replacement - Anticoagulation INR Targets and Antiplatelet by Valve Type

Bioprosthetic valves require at least
VHD Guidelines) ... valve (2017 AHA/ACC ... VHD Guidelines ... #Management #Cardiology ... #Target #DOAC #Table
Natural history
Aneurysms may progress in size as a result of gradual wall weakening [6], with rupture
Table 1: Annual ... References: Radiology ... Brewster DC et al ... . (2003) Guidelines ... 37:1106-1117 #Management
Table of Common Rate Control Agents via AHA/ACC/HRS Guidelines #Management #Pharm #EM #IM #Cardiology #Afib #Common
Table of Common ... Agents via AHA/ACC ... /HRS Guidelines ... #Management #Pharm ... #EM #IM #Cardiology
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
• Avoid ARB/ACE-I ... Delivery • Stable ... e.g., <50%), ESC guidelines ... GDMT meds (e.g., ACE ... #cardiology #treatment
Perhaps quite too often, the knee-jerk reaction to an elevated Troponin is to call our friends
too often, the knee-jerk ... our friends from Cardiology ... are typically able ... “one size fits all ... echocardiogram #management